BioCentury
ARTICLE | Finance

Consortia cross-talk

Collaboration across translational research consortia increases effectiveness

January 15, 2015 8:00 AM UTC

There's no doubt that the consortium model is here to stay, but the challenge now is to avoid creating a bureaucracy of committees with duplicate missions and redundancies of effort. The answer might be a network of coordinated consortia, but bringing more academics into the fold could be critical for success.

Consortia have emerged as a specialized form of public-private partnership that join multiple partners from academic, industry, regulatory and other government or non-government organizations to achieve common goals. The model has gained traction in the last decade as stakeholders have looked for ways to make academics' work more directly relevant to the requirements for developing drugs, and bring fresh thinking to pharmas that want access to cutting edge science. ...